Company Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Jafron Biomedical Co.,Ltd.

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 06/05/2024 BST			5-day change	1st Jan Change
29.09 ^CNY	-1.09%		+7.34%	+30.86%

04-25	Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-03	Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.	CI

Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.

Number of employees: 2,408

CNY in Million	2022	Weight	2023	Weight	Delta
Disposable Blood Perfusion Device 76.4 %	2,025	81.3 %	1,468	76.4 %	-27.50%
Blood Purification Equipment 12.3 %	198	7.9 %	236	12.3 %	+19.26%
Disposable Plasma Bilirubin Absorber 4.8 %	115	4.6 %	92	4.8 %	-20.13%
Other 3.6 %	79	3.2 %	70	3.6 %	-11.58%
Hemodialysis Powder and Liquid Products 2.9 %	75	3.0 %	57	2.9 %	-24.09%

CNY in Million	2022	Weight	2023	Weight	Delta
China 97.3 %	2,429	97.5 %	1,870	97.3 %	-23.01%
Overseas 2.7 %	62	2.5 %	52	2.7 %	-16.32%

Managers	Title	Age	Since
Fan Dong CEO	Chief Executive Officer	54	31/12/98
Yao Hong Chen BRD	Director/Board Member	45	31/12/12
Feng Li BRD	Director/Board Member	54	31/12/09
Xian Min Tang BRD	Director/Board Member	54	31/07/99
Cong Huang SEC	Corporate Secretary	32	31/05/19
De Zhi Li PRN	Corporate Officer/Principal	58	31/12/04

Members of the board	Title	Age	Since
Guo Qing Guo BRD	Director/Board Member	62	20/04/23
Yan Jun Xu BRD	Director/Board Member	51	20/04/23
Fan Dong CEO	Chief Executive Officer	54	31/12/98
Xian Min Tang BRD	Director/Board Member	54	31/07/99
Zhi Hao Wen BRD	Director/Board Member	58	24/12/13
De Zhi Li		58	-
Feng Li BRD	Director/Board Member	54	31/12/09
Xiao Hong Peng CHM	Chairman	64	14/03/17
Yao Hong Chen BRD	Director/Board Member	45	31/12/12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	807,555,312	388,787,572 ( 48.14 %)	31,364,079 ( 3.884 %)	48.14 %

Name	Equities	%	Valuation
Fan Dong 17.32 %	88,782,967	17.32 %	273 M ¥
GF Fund Management Co., Ltd. 5.234 %	26,826,310	5.234 %	83 M ¥
China Merchants Fund Management Co., Ltd. 4.597 %	23,559,144	4.597 %	72 M ¥
JAFRON BIOMEDICAL CO.,LTD. 2.888 %	14,804,287	2.888 %	46 M ¥
Hwabao WP Fund Management Co., Ltd. 2.479 %	12,704,282	2.479 %	39 M ¥
Xue Jui Guo 1.562 %	8,006,192	1.562 %	25 M ¥
Huan Xin Jiang 1.561 %	8,000,882	1.561 %	25 M ¥
Xian Min Tang 1.045 %	5,354,106	1.045 %	16 M ¥
He Huang 1.025 %	5,254,800	1.025 %	16 M ¥
Tian Hong Asset Management Co., Ltd. 0.7622 %	3,906,467	0.7622 %	12 M ¥

Name	Equities	%	Valuation
Fan Dong 90.23 %	266,348,900	90.23 %	819 M ¥
Xian Min Tang 5.425 %	16,014,319	5.425 %	49 M ¥
Guang Hai Zhang 1.908 %	5,630,687	1.908 %	17 M ¥

Name	Equities	%	Valuation
JAFRON BIOMEDICAL CO.,LTD. 2.89%	14,804,287	2.89%	45,534,582 $

Jafron Biomedical Co., Ltd.

98 Keji 6th Road High-Tech Zone

519085, Zhuhai

http://www.jafron.com

address Jafron Biomedical Co.,Ltd.(300529)

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

29.09 CNY

Average target price

30.94 CNY

Spread / Average Target

+6.38%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
JAFRON BIOMEDICAL CO.,LTD.	+30.86%	3.16B
ABBOTT LABORATORIES	-3.54%	184B
MEDTRONIC PLC	-0.58%	109B
BECTON, DICKINSON AND COMPANY	-2.74%	68.37B
DEXCOM, INC.	+4.84%	51.56B
CENCORA, INC.	+10.40%	44.69B
HOYA CORPORATION	+4.37%	41.49B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.87%	26.75B
WEST PHARMACEUTICAL SERVICES, INC.	+4.61%	26.7B
TERUMO CORPORATION	+15.38%	25.68B

Other Medical Equipment, Supplies & Distribution